• No se han encontrado resultados

DESARROLLO TECNOLOGICO Y ESTUDIO DE ESTABILIDAD DE UNA FORMULACION DE ETOPOSIDO 100 mg SOLUCION INYECTABLE, PARA EL TRATAMIENTO DEL CANCER.

N/A
N/A
Protected

Academic year: 2020

Share "DESARROLLO TECNOLOGICO Y ESTUDIO DE ESTABILIDAD DE UNA FORMULACION DE ETOPOSIDO 100 mg SOLUCION INYECTABLE, PARA EL TRATAMIENTO DEL CANCER."

Copied!
10
0
0

Texto completo

Loading

Referencias

Documento similar

Fuente de emisión secundaria que afecta a la estación: Combustión en sector residencial y comercial Distancia a la primera vía de tráfico: 3 metros (15 m de ancho)..

La campaña ha consistido en la revisión del etiquetado e instrucciones de uso de todos los ter- mómetros digitales comunicados, así como de la documentación técnica adicional de

You may wish to take a note of your Organisation ID, which, in addition to the organisation name, can be used to search for an organisation you will need to affiliate with when you

Where possible, the EU IG and more specifically the data fields and associated business rules present in Chapter 2 –Data elements for the electronic submission of information

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

This section provides guidance with examples on encoding medicinal product packaging information, together with the relationship between Pack Size, Package Item (container)

If certification of devices under the MDR has not been finalised before expiry of the Directive’s certificate, and where the device does not present an unacceptable risk to health

In addition to the requirements set out in Chapter VII MDR, also other MDR requirements should apply to ‘legacy devices’, provided that those requirements